Commonwealth Equity Services’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15
| Closed | -$2K | – | 3844 |
|
|
2022
Q4 | $2K | Buy |
15
+4
| +36% | +$533 | ﹤0.01% | 3694 |
|
|
2022
Q3 | $5K | Sell |
11
-1
| -8% | -$455 | ﹤0.01% | 3642 |
|
|
2022
Q2 | $10K | Hold |
12
| – | – | ﹤0.01% | 3623 |
|
|
2022
Q1 | $30K | Buy |
12
+1
| +9% | +$2.5K | ﹤0.01% | 3629 |
|
|
2021
Q4 | $28K | Sell |
11
-1
| -8% | -$2.55K | ﹤0.01% | 3581 |
|
|
2021
Q3 | $53K | Buy |
+12
| New | +$53K | ﹤0.01% | 3495 |
|
|
2021
Q1 | – | Sell |
-16
| Closed | -$125K | – | 3451 |
|
|
2020
Q4 | $125K | Buy |
16
+5
| +45% | +$39.1K | ﹤0.01% | 3029 |
|
|
2020
Q3 | $107K | Buy |
+11
| New | +$107K | ﹤0.01% | 2867 |
|
|
2020
Q2 | – | Sell |
-11
| Closed | -$51K | – | 2996 |
|
|
2020
Q1 | $51K | Buy |
+11
| New | +$51K | ﹤0.01% | 2681 |
|
|
2019
Q3 | – | Sell |
-10
| Closed | -$65K | – | 2870 |
|
|
2019
Q2 | $65K | Hold |
10
| – | – | ﹤0.01% | 2677 |
|
|
2019
Q1 | $83K | Sell |
10
-2
| -17% | -$16.6K | ﹤0.01% | 2627 |
|
|
2018
Q4 | $66K | Buy |
+12
| New | +$66K | ﹤0.01% | 2545 |
|